Skip to main content
Erschienen in: BMC Neurology 1/2016

Open Access 01.12.2016 | Erratum

Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression

verfasst von: Diego Santos-García, Pablo Mir, Esther Cubo, Lydia Vela, Mari Cruz Rodríguez-Oroz, Maria José Martí, José Matías Arbelo, Jon Infante, Jaime Kulisevsky, Pablo Martínez-Martín, COPPADIS Study Group

Erschienen in: BMC Neurology | Ausgabe 1/2016

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The online version of the original article can be found under doi:10.​1186/​s12883-016-0548-9.
The online version of the original article can be found at http://​dx.​doi.​org/​10.​1186/​s12883-016-0548-9.

Erratum

After publication of the original article [1], it has come to the authors’ attention that there were a number of errors in the manuscript which were not identified at proofing. These errors affect the affiliations, Table 2, and the COPPADIS study group collaborators listed in the Acknowledgements section.
Table 2
Centers, number of patients that they have estimated to recruit and distribution of patients selected for the complementary studies according to the different centers
Principal Investigator; PI’s participating site
City
Patients (n)
Controls (n)
Complementary studies (PDP/CS)
1.
Diego Santos García; Neurology Section, Hospital Arquitecto Marcide, Complejo Hospitalario Universitario de Ferrol (CHUF).
Ferrol (A Coruña)
60
10
45/10
2.
(1) Oriol de Fábregues-Boixar Nebot and (2) Jorge Hernández Vara; Movement Disorders Unit, Neurology Service, Hospital Universitario Vall d’Hebron.
Barcelona
60 (40/20)
20 (10/10)
40/20
3.
Carmen Borrue Fernández; Movement Disorders Unit, Neurology Service, Hospital Infanta Sofía.
Madrid
50
10
NO
4.
Pablo Mir Rivera; Movement Disorders Unit, Neurology and Clinical Neurophysiology Service, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío, CSIC and Universidad de Sevilla.
Seville
40
10
40/0
5.
Maria José Martí Domenech; Parkinson’s and Movement Disorders Unit, Neurology Service, Instituto Clínico de Neurociencias, Hospital Clínic.
Barcelona
40
10
NO
6.
Miquel Aguilar Barberá; Movement Disorders Unit, Hospital Universitario Mutua de Terrassa.
Barcelona
40
10
30/10
7.
Beatriz Tijero Merino; Functional Neurology and Parkinson’s Disease Unit, Hospital de Cruces.
Bilbao
35–40
10
NO
8.
José Chacón Peña; Neurology Unit, Hospital Infanta Luisa.
Seville
30–35
10
NO
9.
(1) Manuel Seijo Martínez and (2) Iria Cabo López; Neurology Section, Hospital de Pontevedra.
Pontevedra
30 (15/15)
20 (10/10)
NO
10.
Víctor Puente Périz; Movement Disorders Unit, Neurology Service, Hospital del Mar.
Barcelona
25–30
10
20/10
11.
Inés Legarda Ramiréz; Neurology Service, Hospital Universitario Son Espases.
Palma de Mallorca
25
10
NO
12.
Francisco Carrillo Padilla; Neurology Service, Hospital Universitario de Canarias, San Cristóbal de la Laguna.
Santa Cruz de Tenerife
25
10
20/0
13.
Lydia López Manzanares; Movement Disorders Unit, Neurology Service, Hospital La Princesa.
Madrid
25
10
NO
14.
Caridad Valero Merino; Neurology Unit, Hospital Arnau de Vilanova.
Valencia
20–25
10
NO
15.
Jaime Kulisevsky Bojarski; Movement Disorders Unit, Neurology Service, Hospital de Sant Pau.
Barcelona
20
10
NO
16.
José Manuel García Moreno; Movement Disorders Unit, Hospital Universitario Virgen Macarena.
Seville
20
10
20/10
17.
Benito Galeano Bilbao; Neurology Section, Hospital Universitario de Ceuta.
Ceuta
20–25
10
20/0
18.
Nuria Caballol Pons; Movement Disorders Unit, Consorci Sanitari Integral, Hospital Moisés Broggi.
Sant Joan Despí
20
10
NO
19.
Mari Cruz Rodríguez Oroz; Hospital Universitario Donostia, Instituto de Investigación Biodonostia.
San Sebastián
20
10
20/10
20.
María Iciar Gastón Zubimendi; Movement Disorders Unit, Neurology Service, Complejo Hospitalario de Navarra.
Pamplona
20
10
NO
21.
Pilar Sánchez Alonso; Neurology Service, Hospital Puerta de Hierro.
Madrid
15–25
10
NO
22.
Esther Cubo Delgado; Neurology Service, Complejo Asistencial Universitario de Burgos.
Burgos
15
10
NO
23.
Lydia Vela Desojo; Neurology Unit, Fundación Hospital de Alcorcón.
Alcorcón (Madrid)
15
10
NO
24.
Maria José Catalán Alonso; Movement Disorders Unit, Neurology Service, Hospital Clínico San Carlos.
Madrid
15
10
NO
25.
Luis Manuel López Díaz; Neurology Section, Hospital da Costa.
Burela (Lugo)
15
10
NO
26.
Maria Gema Alonso Losada; Neurology Service, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo (CHUVI).
Vigo (Pontevedra)
15
10
NO
27.
Nuria López Ariztegui; Movement Disorders Unit, Complejo Hospitalario de Toledo.
Toledo
15
10
NO
28.
Mónica Kurtis Urra; Movement Disorders Unit, Neurology Service, Hospital Ruber Internacional.
Madrid
15
10
NO
29.
Jon Infante Ceberio; Movement Disorders Unit, Neurology Service, Hospital Universitario Marqués de Valdecilla.
Santander
15
10
15/10
30.
Sonia Escalante Arroyo; Neurology Service, Hospital de Tortosa Verge de la Cinta (HTVC).
Tortosa (Tarragona)
15
10
15/10
31.
Juan Carlos Martínez Castrillo; Movement Disorders Unit, Neurology Service, Hospital Ramón y Cajal.
Madrid
15
10
NO
32.
José Matías Arbelo González; Movement Disorders and Parkinson’s Disease Unit, Neurology Service, Hospital Universitario Insular de Gran Canaria.
Las Palmas de Gran Canaria
15
10
NO
33.
René Ribacoba Montero; Movement Disorders Unit, Neurology Service, Hospital Central de Asturias.
Oviedo
15
10
15/10
34.
Jessica González Ardura; Neurology Service, Hospital Universitario Lucus Augusti (HULA).
Lugo
15
10
NO
35.
Javier López del Val; Movement Disorders Unit, Neurology Service, Hospital Clínico Universitario Lozano Blesa.
Zaragoza
15
10
NO
36.
María Asunción Ávila Rivera; Movement Disorders Unit, Consorci Sanitari Integral, Hospital General de L’Hospitalet.
L’Hospitalet de Llobregat
15
10
NO
37.
Hortensia Alonso Navarro; Neurology Section, Hospital Universitario del Sureste, Madrid.
Madrid
15
10
NO
38.
Berta Solano Vila; Neurology Service, Hospital Josep Trueta and Parc Martí i Juliá, Girona.
Girona
15
10
15/10
39.
Juan García Caldentey; Neurology Unit, Centro Neurológico OMS 42.
Palma de Mallorca
15
10
NO
40.
Ana Rojo Sebastián; Parkinson’s and Abnormal Movement Unit, Neurology Service, Hospital Universitario Príncipe de Asturias.
Alcalá de Henares (Madrid)
15
10
NO
41.
Silvia Martí Martínez; Neurology Service, Hospital General de Alicante.
Alicante
15
10
NO
42.
José Andrés Domínguez Morán; Neurology Unit, Hospital de la Rivera.
Alcira (Valencia)
15
10
NO
43.
Irene Martínez Torres; Movement Disorders Unit, Neurology Service, Hospital La Fe.
Valencia
15
10
NO
44.
María Álvarez Sauco; Neurology Service, Hospital General Universitario de Elche.
Elche (Alicante)
15
10
NO
45.
Cristina Prieto Jurczynska; Movement Disorders Unit, Hospital Infanta Elena-Hospital Rey Juan Carlos-Hospital Collado Villalba, Madrid.
Madrid
15
10
NO
   
1.000
470
315/110
In the author list, J. Infante should have been affiliated with institutions 3 and 9, rather than just 9, as appears correctly in the author list of this erratum.
There were a number of errors in Table 2, involving the names of institutions listed in column 1. Minor errors were present in institutions 25 (Hospital da Costa, Burela), and 39 (Centro Neurológico OMS 42) within the table. In addition, the ‘Complementary studies’ column of institution 38 (Hospital Josep Trueta and Parc Martí i Juliá) should have read ‘15/10’. As a result, the row of totals found at the bottom of Table 2 was incorrect for this column, and should have read ‘315/110’.
Table 2 appears correctly in this erratum.
Finally, there were errors in the COPPADIS Study group (collaborators) section. The sentence “Finally, this author will not participate in the study” was mistakenly included between the names of Ferriol MM and Leiva C. In addition, the collaborator Clemente J should have appeared as ‘Segundo JC’.
Within the affiliations of this section, the city names of institutions 19 (Hospital Clínico San Carlos, Madrid) and 20 (Hospital da Costa, Burela, Lugo) appear incorrectly.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, et al. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression. BMC Neurol. 16;26. doi:10.1186/s12883-016-0548-9. Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, et al. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression. BMC Neurol. 16;26. doi:10.​1186/​s12883-016-0548-9.
Metadaten
Titel
Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression
verfasst von
Diego Santos-García
Pablo Mir
Esther Cubo
Lydia Vela
Mari Cruz Rodríguez-Oroz
Maria José Martí
José Matías Arbelo
Jon Infante
Jaime Kulisevsky
Pablo Martínez-Martín
COPPADIS Study Group
Publikationsdatum
01.12.2016
Verlag
BioMed Central
Erschienen in
BMC Neurology / Ausgabe 1/2016
Elektronische ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-016-0567-6

Weitere Artikel der Ausgabe 1/2016

BMC Neurology 1/2016 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.